Drägerwerk AG & Co. Records Significant Growth in First Nine Months of 2026

Drägerwerk AG & Co. KGaA reported increased net sales and earnings for the first nine months of 2026. Order intake rose by EUR 79 million to EUR 2,674 million. Both divisions contributed to a net sales increase of EUR 110 million, reaching EUR 2,454 million. EBIT improved by EUR 35 million to EUR 111.8 million, driven by customs refunds.

Demand for "Technology for Life" products grew, particularly in the EMEA and APAC regions. While Germany showed strong demand, the Americas recorded a decline due to a high comparative base last year. The safety division's order intake grew by 13.1%, offsetting a 3.5% decline in the medical division.

Despite macroeconomic challenges, Dräger remains optimistic, forecasting annual net sales growth of 2% to 6% and an EBIT margin between 6% and 8% for 2026.